Pharmaceuticals
Pharma - Formulators
from 2,576 today
We reduce our earnings estimate for FY27 by 4%, factoring in muted performance of the consumer health segment. We value MANKIND at 40x 12M forward earnings to arrive at a TP of INR2,975. Reiterate BUY.
Ratings and target prices as published by each firm. Each summary condenses that firm's stated view in its own note and is attributed to it; no report text is reproduced.
